NASDAQ
Anavex Life Sciences Corp. (AVXL) has a free cash flow growth of 16.89% as of Friday, May 29, 2026. This represents a 160.19% increase compared to its 12-month average of -28.06%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.